Deep Genomics: Toronto genomics company expands to Cambridge
In 2021, with $180 million of Series C funding and expansion ideas, Deep Genomics set its sights on Boston.
Read full article »
Deep Genomics is a Canada-based biopharmaceutical company that researches and develops AI-driven RNA therapeutics for the treatment of genetic conditions.
Read more